AdvisorShares Investments’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,722
Closed -$1.4M 310
2024
Q3
$1.4M Sell
11,722
-750
-6% -$100K 0.27% 41
2024
Q2
$1.81M Sell
12,472
-1,016
-8% -$135K 0.32% 42
2024
Q1
$1.73M Sell
13,488
-1,210
-8% -$144K 0.29% 42
2023
Q4
$1.52M Buy
+14,698
New +$1.45M 0.36% 36

Other funds holding NVO

AdvisorShares Investments's NVO Position: Q4 2024 in Review

AdvisorShares Investments sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 11,722 shares — an estimated $1.4M sold.

AdvisorShares Investments first reported a position in NVO in Q4 2023 and held it in 4 quarters. The position peaked at $1.81M in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • AdvisorShares Investments reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • AdvisorShares Investments sold 11,722 Novo Nordisk shares in Q4 2024, an estimated $1.4M.
  • AdvisorShares Investments first reported a position in Novo Nordisk in Q4 2023 and held it in 4 quarters.
  • AdvisorShares Investments's Novo Nordisk position peaked at $1.81M in Q2 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on AdvisorShares Investments's 13F filing for Q4 2024, filed 14 Feb 2025.